Uso cronico dell’associazione estemporanea ACE-inibitori e beta-bloccanti in Italia dal 2013 al 2019 attraverso i dati amministrativi sanitari — Silvia Calabria (2021) | RDL Network
Uso cronico dell’associazione estemporanea ACE-inibitori e beta-bloccanti in Italia dal 2013 al 2019 attraverso i dati amministrativi sanitari
Article 2021 en
Authors
SC
Silvia Calabria
CP
Carlo Piccinni
GR
Giulia Ronconi
Abstract
1 min read
These findings, together with recommendations from the main international guidelines encourage to make available also ramipril and bisoprolol as fixed dose combination, in order to simplify the therapy administration and improve the adherence, especially among elderly and patients with multimorbidity.
Franco Muggli, Gianfranco Parati, Isabella Hunjan, Clara Stroppa, Mario G. Bianchetti, Bienvenu Muvunyi, Evariste Ntaganda, Alice Umulisa, Vincent Sinabubaraga, Dragana Radovanović
Michael D. Jensen, Donna H. Ryan, Karen A. Donato, Caroline M. Apovian, Jamy D. Ard, Anthony G. Comuzzie, Frank B Hu, Van S. Hubbard, John M. Jakicic, Robert F. Kushner, Catherine M. Loria, Barbara E. Millen, Cathy Nonas, F. Xavier Pi‐Sunyer, June Stevens, Victor J. Stevens, Thomas A. Wadden, Bruce M. Wolfe, Jack A. Yanovski
Chloe Pek Sang Tang, Professor Gregory Lip, Terry McCormack, Alexander R. Lyon, Peter Hillmen, Sunil Iyengar, Nicolás Martínez‐Calle, Nilima Parry‐Jones, Piers Patten, Anna Schuh, Renata Walewska
Discussion(0)
No comments yet. Be the first to comment.